Urinary incontinence in women

Y Aoki, HW Brown, L Brubaker, JN Cornu… - Nature reviews Disease …, 2017 - nature.com
Urinary incontinence symptoms are highly prevalent among women, have a substantial
effect on health-related quality of life and are associated with considerable personal and …

Mid‐urethral sling operations for stress urinary incontinence in women

AA Ford, L Rogerson, JD Cody… - Cochrane Database …, 2017 - cochranelibrary.com
Background Urinary incontinence is a very common and debilitating problem affecting about
50% of women at some point in their lives. Stress urinary incontinence (SUI) is a …

The rising worldwide impact of benign prostatic hyperplasia

BM Launer, KT McVary, WA Ricke… - BJU international, 2021 - Wiley Online Library
Objectives To describe the trend in the impact of lower urinary tract symptoms attributed to
benign prostatic hyperplasia (LUTS/BPH) on a global scale using the Global Burden of …

Worldwide prevalence estimates of lower urinary tract symptoms, overactive bladder, urinary incontinence and bladder outlet obstruction

DE Irwin, ZS Kopp, B Agatep, I Milsom… - BJU …, 2011 - Wiley Online Library
Study Type–Symptom prevalence (prospective cohort) Level of Evidence 1b What's known
on the subject? and What does the study add? Few prevalence studies used current ICS …

Pelvic floor dysfunction and its effect on quality of sexual life

M Verbeek, L Hayward - Sexual medicine reviews, 2019 - academic.oup.com
Introduction Pelvic floor disorders (PFD) are extremely common; 1 in 3 parous women will
experience urinary incontinence, 1 in 2 will develop pelvic organ prolapse, whereas 1 in 10 …

International Continence Society (ICS) report on the terminology for nocturia and nocturnal lower urinary tract function

H Hashim, MH Blanker, MJ Drake… - Neurourology and …, 2019 - Wiley Online Library
Introduction The terminology for nocturia and nocturnal lower urinary tract function is
reviewed and updated in a clinically and practically‐based consensus report. Methods This …

Global prevalence and economic burden of urgency urinary incontinence: a systematic review

I Milsom, KS Coyne, S Nicholson, M Kvasz, CI Chen… - European urology, 2014 - Elsevier
Context The prevalence and economic burden of urgency urinary incontinence (UUI) are
difficult to ascertain because of overlap with data on overactive bladder and other types of …

OnabotulinumtoxinA for the treatment of patients with overactive bladder and urinary incontinence: results of a phase 3, randomized, placebo controlled trial

VW Nitti, R Dmochowski, S Herschorn… - The Journal of …, 2013 - auajournals.org
Purpose: Overactive bladder affects 12% to 17% of the general population and almost a
third experience urinary incontinence, which may severely impact health related quality of …

Efficacy and tolerability of mirabegron, a βべーた3-adrenoceptor agonist, in patients with overactive bladder: results from a randomised European–Australian phase 3 trial

V Khullar, G Amarenco, JC Angulo, J Cambronero… - European urology, 2013 - Elsevier
BACKGROUND: Mirabegron, a βべーた3-adrenoceptor agonist, has been developed for the
treatment of overactive bladder (OAB). OBJECTIVE: To assess the efficacy and tolerability of …

OnabotulinumtoxinA 100 U significantly improves all idiopathic overactive bladder symptoms and quality of life in patients with overactive bladder and urinary …

C Chapple, KD Sievert, S MacDiarmid, V Khullar… - European urology, 2013 - Elsevier
Background Overactive bladder (OAB) syndrome with urinary incontinence (UI) is prevalent
in the population and impairs health-related quality of life (HRQOL). Objective To assess the …